Literature DB >> 2788194

A fluorescence sandwich ELISA for detecting soluble and cell-associated human interleukin-2.

K Kitamura1, K Matsuda, M Ide, T Tokunaga, M Honda.   

Abstract

A fluorescence sandwich ELISA was developed for the quantitation of human interleukin-2 (IL-2) using a combination of two anti-human IL-2 antibodies, L61 and biotinylated anti-IL-2 rabbit IgG. The minimum level of IL-2 detectable by this ELISA was 0.3 pg/ml, indicating that this method is about 100 times more sensitive than the usual colorimetric human IL-2 ELISA. The ELISA specifically detected human IL-2 in cell culture supernatants and serum, and also in extracts from mitogen-stimulated peripheral blood mononuclear cells. All of the IL-2 species detected in the supernatants, sera and cell lysates were shown to have a molecular weight of 15,000, as estimated by size exclusion high performance liquid chromatography.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2788194     DOI: 10.1016/0022-1759(89)90172-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Specific immunotherapy with tumour-draining lymph node cells cultured with both anti-CD3 and anti-CD28 monoclonal antibodies.

Authors:  M Harada; T Okamoto; K Omoto; K Tamada; M Takenoyama; C Hirashima; O Ito; G Kimura; K Nomoto
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

2.  T-Cell hyporesponsiveness induced by activated macrophages through nitric oxide production in mice infected with Mycobacterium tuberculosis.

Authors:  S Nabeshima; M Nomoto; G Matsuzaki; K Kishihara; H Taniguchi; S Yoshida; K Nomoto
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

3.  Specific antitumor activity of tumor-infiltrating lymphocytes expanded first in a culture with both anti-CD3 monoclonal antibody and activated B cells and then in a culture with interleukin-2.

Authors:  K Tamada; M Harada; T Okamoto; M Takenoyama; O Ito; G Matsuzaki; K Nomoto
Journal:  Cancer Immunol Immunother       Date:  1995-12       Impact factor: 6.968

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.